Skip to main content
Equibles

Squarepoint Ops LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1642575 NEW YORK, NY
Back to CRSP Full portfolio

Position in CRSP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,641,472
+$8,335,910 QoQ
Shares Held
286,789
+86.7% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#33
of 521 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Derivatives in CRSP

reported options exposure · as of Jun 30, 2026
CallValue
$229,068
CallShares
4,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. CRSP ranks #21 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in CRSP

Export CSV
49 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $229,068 4,200
2026-06-30 $15,641,472 286,789
2026-03-31 $485,214 10,200
2026-03-31 $470,943 9,900
2026-03-31 $7,305,562 153,575
2025-12-31 $30,473,303 581,108
2025-12-31 $2,637,732 50,300
2025-12-31 $3,749,460 71,500
2025-09-30 $4,225,612 65,200
2025-09-30 $6,973,556 107,600
2025-06-30 $520,448 10,700
2025-06-30 $822,016 16,900
2025-06-30 $1,472,721 30,278
2025-03-31 $486,629 14,300
2025-03-31 $735,048 21,600
2025-03-31 $2,485,006 73,024
2024-12-31 $6,539,231 166,139
2024-12-31 $2,668,608 67,800
2024-12-31 $1,605,888 40,800
2024-09-30 $930,204 19,800
2024-09-30 $11,697,033 248,979
2024-09-30 $549,666 11,700
2024-06-30 $637,318 11,800
2024-06-30 $14,519,130 268,823
2024-06-30 $1,598,696 29,600
2024-03-31 $18,677,884 274,030
2024-03-31 $3,762,432 55,200
2024-03-31 $1,090,560 16,000
2023-12-31 $7,972,610 127,358
2023-12-31 $2,003,200 32,000
2023-12-31 $1,195,660 19,100
2023-09-30 $3,263,541 71,900
2023-09-30 $6,585,045 145,077
2023-06-30 $561,400 10,000
2023-06-30 $6,472,942 115,300
2023-06-30 $7,152,909 127,412
2023-03-31 $5,563,290 123,000
2023-03-31 $497,530 11,000
2023-03-31 $5,921,421 130,918
2022-12-31 $5,357,670 131,800
2022-12-31 $1,288,605 31,700
2022-12-31 $6,765,542 166,434
2022-09-30 $2,091,200 32,000
2022-09-30 $4,551,692 69,651
2022-09-30 $8,613,130 131,800
2021-06-30 $874,206 5,400
2021-03-31 $1,444,166 11,852
2020-12-31 $773,971 5,055
2020-03-31 $573,934 13,533

Report a Problem

Category
Description
Email (optional, for follow-up)